One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   North America Anesthesia Drugs Market

North America Anesthesia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Product Code : MDHC00122330
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Aspen Holdings
- AbbVie Inc.
- AstraZeneca
- Baxter International
- B. Braun Melsungen AG
- Eisai Co. Ltd
- Pfizer Inc.
- F. Hoffmann-La Roche AG
- Fresenius SE & Co. KGaA
- Novartis AG (Sandoz)
- Piramal Enterprises Limited

[Report Description]

The North American anesthesia drugs market is expected to register a CAGR of nearly 3.5% during the forecast period.

According to the United States Census Bureau’s Statistics, as of 2017, the total number of people aged 65 years and older had exceeded 50 million, and between 2020 and 2030, the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 years and older is expected to be more than triple from an estimated 6 million in the present scenario, to nearly 20 million by 2060. Elderly patients are likely to be having higher perioperative morbidity and mortality. The older population tends to have more critical diseases, which puts them at an increased risk for perioperative morbidity. The geriatric population is also at a higher risk of organ function failures, as there are changes in the pharmacokinetics and pharmacodynamics related to age and organ function. As the proportion of older patients increases, there will be an increased patient risk with cardiac and pulmonary diseases, alterations in kidney and liver function, and respiratory and urinary tract complications. The overall increase in the number of surgeries performed will have a strong impact on the anesthetics market, thus boosting the growth of the market in this region.

Key Market Trends

Propofol sub-segment by General Anesthesia Drugs, is Expected to Show the Healthy Growth

Propofol is a drug that has been used for a long time for various surgical procedures requiring anesthesia. With the increase in the number of surgeries and the increasing geriatric population in the region, the segment growth also increases. Some of the companies which manufacture propofol injections are Neon Laboratories Limited, Bharat Serums and Vaccines Limited, and Fresenius Kabi, having a good global presence and well-established distribution channel for the drugs in this segment. The drug is always in demand in the market for utilization in different types of surgeries, and is expected to witness rapid growth in the coming years.

Competitive Landscape

The North American anesthesia drugs market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with rising drug approvals, mid-size to smaller companies are increasing their market presence by introducing new ingredients with fewer prices. Companies, like Baxter International, Fresenius SE & Co. KGaA, Eisai Co. Ltd, Roche Holding AG, and B. Braun Melsungen AG, hold substantial market shares in the anesthesia drugs market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Surgeries
4.2.2 Growing Investment in R&D by the Pharmaceutical Companies
4.3 Market Restraints
4.3.1 Side Effects of General Anesthetics
4.3.2 Regulatory Issues
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Drug Type
5.1.1 General Anesthesia Drugs Propofol Sevoflurane Desflurane Dexmedetomidine Remifentanil Midazolam Isoflurane Other General Anesthesia Drugs
5.1.2 Local Anesthesia Drugs Bupivacaine Ropivacaine Lidocaine Chloroprocaine Articaine Benzocaine Other Local Anesthesia Drugs
5.2 By Route of Administration
5.2.1 Inhalation
5.2.2 Injection
5.2.3 Other Routes of Administration
5.3 By Application
5.3.1 General Surgeries
5.3.2 Plastic Surgery
5.3.3 Cosmetic Surgeries
5.3.4 Dental Surgeries
5.3.5 Other Applications
5.4 Geography
5.4.1 North America United States Canada Mexico

6.1 Company Profiles
6.1.1 Aspen Holdings
6.1.2 AbbVie Inc.
6.1.3 AstraZeneca
6.1.4 Baxter International
6.1.5 B. Braun Melsungen AG
6.1.6 Eisai Co. Ltd
6.1.7 Pfizer Inc.
6.1.8 F. Hoffmann-La Roche AG
6.1.9 Fresenius SE & Co. KGaA
6.1.10 Novartis AG (Sandoz)
6.1.11 Piramal Enterprises Limited


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports